- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Patients With Suspected Prostate Cancer in Belgium
Total 238 results
-
Universitaire Ziekenhuizen KU LeuvenAZ Sint-Jan AV; General Hospital Groeninge; AZ Sint-Blasius DendermondeRecruitingProstate Cancer | Adenocarcinoma of the Prostate | Locally Advanced Prostate Carcinoma | Locally Advanced Prostate AdenocarcinomaBelgium
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
Epizyme, Inc.Active, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, Belgium
-
Novosanis NVUniversiteit AntwerpenWithdrawnProstate Cancer | Urine | Liquid BiopsyBelgium
-
Cliniques universitaires Saint-Luc- Université...WithdrawnPatients With High Cholesterol Levels Needing a Lipid-lowering TherapyBelgium
-
Cliniques universitaires Saint-Luc- Université...CompletedProstate Cancer | Primary DiseaseFrance, Belgium
-
Universitaire Ziekenhuizen KU LeuvenUnknownStudying Spinal Cord Evoked Potentials in Patients With Intractable Pain.Belgium
-
Universitaire Ziekenhuizen KU LeuvenIpsenRecruiting
-
Astellas Pharma IncMedivation, Inc.CompletedProstate CancerBelgium, Czechia, Denmark, Germany
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
Universitaire Ziekenhuizen KU LeuvenRecruitingProstate Cancer | Radiotherapy | SBRTBelgium
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Novartis PharmaceuticalsCompleted
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast CancerSpain, Czechia, Peru, Russian Federation, Austria, Lithuania, Poland, South Africa, Italy, Ukraine, Israel, Argentina, Belgium, Brazil, France, Hungary, Japan, Latvia, Panama
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Cliniques universitaires Saint-Luc- Université...Ferring PharmaceuticalsUnknown
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedMetastatic Castration-Resistant Prostate CancerBelgium, France, Germany, Spain, United Kingdom
-
Astellas Pharma IncCompleted
-
Radboud University Medical CenterJohns Hopkins University; University Health Network, Toronto; Medical University... and other collaboratorsCompletedProstate CancerUnited States, Austria, Belgium, Canada, Germany, Netherlands, Norway, United Kingdom
-
Bracco Diagnostics, IncBracco Imaging S.p.A.TerminatedProstate CancerItaly, Austria, France, Netherlands, Belgium, Germany, United Kingdom
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
AstraZenecaParexelCompletedProgressive Metastatic Castrate-Resistant Prostate CancerUnited States, Spain, Belgium, France, Korea, Republic of
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Ferring PharmaceuticalsCompleted
-
European Organisation for Research and Treatment...CompletedProstate CancerNetherlands, Belgium, Israel, Malta, Russian Federation, Turkey, United Kingdom
-
European Organisation for Research and Treatment...CompletedProstate CancerFrance, Spain, Belgium, Switzerland, Israel, Germany
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
AmgenActive, not recruitingNeuroendocrine Prostate CancerBelgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
-
University GhentUniversity Hospital, GenevaActive, not recruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic CancerNorway, Spain, Belgium, Switzerland, Australia, Italy
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Centocor Research & Development, Inc.CompletedProstate CancerUnited States, United Kingdom, Belgium, Russian Federation
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
Ferring PharmaceuticalsCompletedProstate CancerBelgium, Germany, Hungary, Netherlands, Romania, Russian Federation, South Africa
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstate CancerBelgium, Czech Republic, France, Germany, Poland, Spain, United Kingdom
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Cancer Research AntwerpBayer; Veracyte, Inc.Recruiting
-
General Hospital GroeningeCompletedCognitive Impairment | Elderly Cancer PatientsBelgium
-
Ferring PharmaceuticalsCompletedProstate CancerFinland, Belgium, Netherlands, Russian Federation, Germany, Romania, United Kingdom, France, Montenegro, Serbia
-
European Organisation for Research and Treatment...CompletedProstate CancerBelgium, Italy, France, Netherlands, United Kingdom, Poland, Ireland, Spain, Cyprus, Czech Republic, Luxembourg
-
Janssen Pharmaceutica N.V., BelgiumCompletedProstate CancerUnited Kingdom, Belgium, Hungary, Germany
-
European Organisation for Research and Treatment...CompletedProstate Cancer | Metastatic CancerNetherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom